Today's Healthcare Pulse
Pharma Shifts Ad Spend to Spot TV Amid Heightened FDA Scrutiny
Pharmaceutical advertisers are redirecting dollars toward spot television placements as the FDA intensifies its oversight of drug marketing. The trend reflects a strategic move to capture audiences with shorter, targeted ads while navigating tighter regulatory expectations.
Also developing:
By the numbers: Apogee Therapeutics secures $1.3B royalty financing
Advocacy, and Physical Fitness, Needed to Stem Pain-Related Cath Lab Injury
Interventional cardiologists gathered at the SCAI 2026 meeting to confront rising musculoskeletal injuries tied to heavy lead aprons and awkward cath‑lab postures. Dr. Allison Dupont highlighted that a 15‑lb apron can generate 200‑300 psi on lumbar discs, and 21% of her peers have taken leave for orthopedic issues. Panelists advocated for two‑piece lead gear, lead‑free radiation systems, and structured exercise regimens to mitigate pain. Institutional support and advocacy were identified as critical to implementing these ergonomic solutions.
Drug Trials Snapshots: ELREXFIO
Pfizer’s ELREXFIO (elranatamab‑bcmm) received accelerated FDA approval on Aug 14 2023 for relapsed/refractory multiple myeloma after at least four prior therapies. The approval rests on a single‑arm trial of 187 patients, with 97 efficacy‑eligible participants showing a 57.7% objective response rate, including...
Mediterranean Diet Cuts 10‑Year Heart Disease Risk by 47%, Study Finds
Researchers from Harokopio University reported that Greeks who closely followed a Mediterranean diet were 47% less likely to develop cardiovascular disease over a decade. The findings, presented at the American College of Cardiology’s 64th Scientific Session, bolster existing dietary recommendations...
Feeding Difficulties Linked to Higher Postnatal Depression Risk, Study Shows
A recent analysis of UK data reveals that mothers who encounter infant feeding problems are at a markedly higher risk of postnatal depression. The findings, highlighted by lactation expert Jackie Hall, underscore a gap in NHS support during the critical...
2026 Meta‑Analysis Shows Time‑Restricted Eating Cuts Weight and Improves Metabolism
Researchers released a 2026 network meta‑analysis confirming that time‑restricted eating (TRE) in 8‑10‑hour windows leads to modest weight loss, lower systolic blood pressure and improved lipid profiles. The study also flags potential heart‑risk signals for windows under eight hours, sparking...
Pfizer Pushes Elrexfio Into Earlier Multiple Myeloma Line After Phase III Success
Pfizer will ask regulators to approve Elrexfio (elranatamab) as a second‑line treatment for relapsed/refractory multiple myeloma after the MagnetisMM-5 Phase III trial met its primary endpoint. The study, which enrolled 944 patients, demonstrated a statistically significant PFS advantage over J&J's...
Active-Duty US Soldiers to Receive MDMA Therapy for PTSD Next Year
The Department of Defense has approved two MDMA‑assisted therapy trials for active‑duty service members, allocating $4.9 million to each of Walter Reed and an Emory‑UT Health partnership. A total of 186 soldiers with PTSD will receive up to three MDMA doses...
Drug Trials Snapshots: VEOPOZ
VEOPOZ (pozelimab‑bbfg) received FDA approval on August 18, 2023 to treat CD55‑deficient protein‑losing enteropathy (CHAPLE disease) in patients of all ages. The decision was based on a single‑arm trial of ten patients enrolled in Turkey, Thailand and the United States, with a...
Abbott Secures FDA Clearance for Ultreon 3.0 AI‑Powered OCT Platform
Abbott announced FDA approval and CE Mark for its Ultreon 3.0 AI‑powered optical coherence tomography platform, enabling real‑time, high‑resolution coronary imaging during PCI procedures. The clearance removes a key regulatory barrier and positions Abbott at the forefront of AI‑driven cardiac...
Axsome Gets FDA Approval for First Non-Antipsychotic Drug to Treat Agitation Associated with Alzheimer’s Dementia
The FDA has expanded the indication for Axsome Therapeutics’ Auvelity, approving it to treat agitation associated with Alzheimer’s disease dementia. This marks the first non‑antipsychotic medication cleared for this distressing symptom. Auvelity, originally approved in 2022 for major depressive disorder,...
Top Psychiatrist Drops Bombshell Testimony: Canadian Government QUIETLY EUTHANIZING MENTALLY ILL PATIENTS
Renowned psychiatrist Dr. John Maher testified before a Canadian parliamentary committee that the Medical Assistance in Dying (MAiD) program is already being applied to patients with severe mental illness, often under dubious clinical justifications. He cited specific cases, including a...
MAHA Scores on Farm Bill but Loses Ally for Surgeon General
The Make America Healthy Again (MAHA) movement secured a win on pesticide liability language in the House farm bill, with a bipartisan 280‑142 vote removing provisions that would have shielded manufacturers. The same day, the White House withdrew the nomination...
Intimate Partner Violence Is a Hidden Contributor to Women’s Suicide
A federal parliamentary inquiry in Australia is uncovering how intimate partner violence (IPV) contributes to a hidden wave of women’s suicides, with coronial data suggesting 28‑56% of female suicides are linked to abuse. Roughly four to eight women die by...
FDA Proposal Would Exclude Bulk Compounding of Weight-Loss Drugs Semaglutide, Tirzepatide, and Liraglutide
The FDA announced a proposal to remove semaglutide, tirzepatide and liraglutide from the 503B bulk drug list, concluding there is no clinical need for outsourcing facilities to compound these GLP‑1 weight‑loss agents from bulk substances. Because FDA‑approved versions are already...
Rising Temperatures Fuel Surge in Thunderstorm Asthma Cases
Scientists warn that warming temperatures are amplifying thunderstorm asthma incidents, a phenomenon that caused over 3,400 severe attacks and 10 deaths in Melbourne in 2016. The trend threatens to overwhelm emergency services as climate‑driven storms become more frequent.
Sanofi Names Belén Garijo CEO, Effective May 1, 2026
Sanofi confirmed that Belén Garijo will assume the role of Chief Executive Officer on May 1, 2026, following the April 29 annual general meeting. The appointment comes as the company declares a €4.12 (≈$4.49) per‑share dividend and refreshes its board...
Oklahoma: As if Work Reporting Won't Cause Enough Damage, GOP Moves to Kill Off Medicaid Expansion Entirely
Oklahoma's Republican legislature is advancing House Bill 4440 and House Joint Resolution 1067 to remove Medicaid expansion from the state constitution and either shift it to statutory law or repeal it entirely. Both measures cleared the Senate Rules Committee along...
Alignment Healthcare Turns A Profit As Medicare Advantage Costs Ease
Alignment Healthcare reported a first‑quarter net income of $11.4 million, a swing from a $9.3 million loss a year earlier. The company’s medical benefit ratio improved to 88.2%, down 25 basis points year‑over‑year, reflecting easing Medicare Advantage costs. Total revenue jumped more...
Conservative Medical Professionals Sue Virginia over Proposed Abortion Rights Amendment
Conservative medical groups and a Bluefield town council member sued Virginia, claiming the ballot language for a proposed constitutional amendment guaranteeing abortion rights is misleading. They contend the wording omits provisions that would eliminate parental notification, remove age‑of‑consent limits, allow...
Intellia Raises $180 M, Files BLA After First In‑Vivo CRISPR Phase 3 Success
Intellia Therapeutics priced a $180 million public offering of 16.7 million shares and filed a rolling Biologics License Application for its hereditary angioedema candidate lonvo‑z after the drug met primary endpoints in the first global in‑vivo CRISPR Phase 3 trial. The dual milestones...
Drug Trials Snapshots: EXXUA
Fabre‑Kramer Pharmaceuticals received FDA approval for EXXUA (gepirone) on September 22, 2023 as a once‑daily oral antidepressant for adult major depressive disorder. The approval was based on two placebo‑controlled, flexible‑dose Phase III trials that enrolled 456 patients, with 442 forming the...
The CDC Says It Is “Following the Evidence.” So Why Hide the Evidence?
The CDC, under acting director Jay Bhattacharya, declined to publish a Morbidity and Mortality Weekly Report that found COVID‑19 vaccination cut emergency‑room visits and hospitalizations by roughly half during the last winter. HHS cited methodological flaws in the study’s test‑negative...
Biomarkers Reveal Burnout Impact on Emergency Care Staff
Burnout and Biological Biomarkers in Emergency and Acute-Care Healthcare Workers: A Systematic Scoping Review with Evidence Mapping https://t.co/q7ajNKrk8t
DOE Issues Final Rule on Updated Definition of ‘Professional Student’
On April 30 the U.S. Department of Education issued a final rule redefining “professional student” and “graduate student” for federal loan eligibility. The rule limits professional student status to 11 specific degree programs, granting up to $50,000 per year and a...
Drug Trials Snapshots: POMBILITI
The FDA approved POMBILITI (cipaglucosidase alfa‑atga) on September 28, 2023 for adult patients with late‑onset Pompe disease (LOPD) weighing ≥ 40 kg who are not responding to existing enzyme replacement therapy. Approval is based on a randomized, double‑blind trial of 123 participants across 61 sites...
President Names Nicole Saphier as New Surgeon General Nominee
President Trump announced on April 30 that radiologist Nicole Saphier, director of breast imaging at Memorial Sloan Kettering Monmouth, has been nominated to serve as the next U.S. surgeon general. The nomination comes as the Senate Health, Education, Labor and Pensions...
New Clues Shed Light on Why Pancreatic Cancer Is so Hard to Treat
University of Rochester researchers identified the gene Dec2 as a key shield that lets pancreatic cancer cells evade T‑cell attack. In mouse models, deleting Dec2 restored immune visibility, suggesting a new therapeutic target. The study also revealed Dec2’s circadian rhythm,...
Senators Introduce AHA-Supported Bill Granting Extension of Medicare Payment Model for Rural Hospitals
Senators Chuck Grassley and Michael Bennet introduced the Rural Community Hospital Demonstration Reauthorization Act, a bipartisan bill that would extend a cost‑based Medicare payment model for rural hospitals by five years. The model applies to facilities with 50 beds or...
AI Spots Pancreatic Cancer Years Before Symptoms Appear, Study Finds
Researchers at the Mayo Clinic unveiled REDMOD, an AI system that can spot early signs of pancreatic cancer on routine CT scans up to three years before a formal diagnosis. In a study of nearly 2,000 scans, the model identified...
Real-World Healthcare Data Drives Students' Research
NHIT’s Data Fusion Center supplied real‑world healthcare data that enabled NHIT INSPIRED interns Belina Sapkota and Sarah Zak to investigate the root causes of rural health gaps in the United States. Their research highlighted chronic provider shortages, limited broadband, and...
How Unhealthy Ultra-Processed Foods Are Designed and Marketed to Make Us Crave Them
New research maps the ultra‑processed food (UPF) ecosystem, showing how manufacturers blend refined carbs, fats and additives to trigger brain reward pathways and suppress satiety. The study identifies eleven reinforcing feedback loops—from product formulation to data‑driven marketing—that drive consumption, especially...
Telehealth Can Provide Rural Healthcare Lifeline
NHIT‑INSPIRED interns Belina Sapkota and Sarah Zak presented a capstone project that proposes expanding telehealth services to bridge the chronic health‑care gap in rural America. Their plan couples broadband‑enabled virtual visits with a curriculum to build an AI‑ready workforce capable...
The Structural Transformation of Healthcare AI: The Ascendance of Forward Deployed Engineering
The Forward Deployed Engineer (FDE) model, originally forged at Palantir, is reshaping healthcare AI by embedding engineers directly within hospital IT environments to bridge the gap between algorithmic potential and production reality. FDEs handle live data integration, MLOps, and regulatory...
Rural Hospitals Are in a Precarious Position, New Research Shows
New research by NHIT INSPIRED reveals that 700 of the 1,800 rural hospitals in the United States are financially at risk, and 300 of them could close within the next three years. The study highlights mounting pressures from low reimbursement...
The Structural Tension at the Heart of MedTech
The article highlights the inherent tension between the deliberate, evidence‑driven pace of MedTech development and the fast‑moving expectations of venture capital. It argues that accelerating clinical validation to meet investor timelines often backfires, leading to underpowered studies and higher downstream...
Trump Withdraws Casey Means as Nominee for Surgeon General
President Donald Trump withdrew Casey Means, his second nominee for U.S. Surgeon General, after Senate opposition over her comments on vaccines and birth control. Means, a leading figure in the Make America Healthy Again (MAHA) movement, had pledged to warn...
ESOC 2026: What to Expect in Maastricht
The 12th European Stroke Organisation Conference (ESOC) convenes in Maastricht from May 6‑8, drawing roughly 4,200 delegates from 100 nations. Six scientific tracks will showcase the latest clinical trial data on stroke prevention, diagnosis, and treatment, including late‑breaking sessions on pre‑hospital...
The Right Exercise Improves Sleep Most for Older Adults with Cognitive Impairment
A Texas A&M study using Oura Rings found that high‑intensity exercise most effectively reduces sleep disturbances in older adults with mild cognitive impairment (MCI). Light activity also helped, but moderate exercise showed no significant impact. The research tracked seven residents...
Who Is Nicole Saphier?
President Trump withdrew Casey Means and, within minutes, nominated Dr. Nicole B. Saphier, a breast‑imaging oncologist at Memorial Sloan Kettering, as his third Surgeon General pick in fifteen months. Saphier is the author of the 2020 bestseller *Make America Healthy...
MedCity FemFwd: Inside Partum Health’s Partnership with UChicago Medicine
Partum Health has partnered with UChicago Medicine in Hyde Park to provide 24/7, Medicaid‑reimbursed doula support for labor, delivery, and postpartum care. The program offers in‑person doulas without referrals, aiming to improve birth outcomes and patient satisfaction for a largely Medicaid‑eligible...
People in Low-Income Areas Are Less Likely to Get Cancer Screenings
A new study of 1,300 federally qualified health centers (FQHCs) serving 29.8 million patients reveals stark gaps in cancer screening rates across socioeconomic lines. Residents of the most resource‑poor neighborhoods receive colorectal screening about 15 percentage points less, breast screening 11 points less,...
Cybersecurity Tactics for Medical IoT Devices
The Internet of Medical Things (IoMT) is projected to surge from $60 billion in 2024 to $814 billion by 2032, driven by real‑time patient monitoring and cost‑saving benefits. However, 2024 saw over 14,000 IoMT IPs exposed, with 36% stemming from unsecured medical...
The Prostate Cancer Recovery Few Men Are Warned About
Physiatrist Dr. Francisco M. Torres, a prostate‑cancer survivor, recounts his unexpected post‑operative challenges after robot‑assisted radical prostatectomy. His experience revealed a systemic failure: patients receive scant guidance on pre‑habilitation and pelvic‑floor rehabilitation, despite strong evidence that these interventions improve continence...
Sorting Through Medicare Myths in Federal Retirement Decisions
Federal retirees face a maze of Medicare myths that can affect their health‑care costs. Adding Medicare Part B costs a base $202.90 per month, but many FEHB plans waive deductibles, copays and coinsurance when Medicare is primary, potentially offsetting the premium....
Asembia ASX26: The Strain on the Development of Infrastructure for Sustainable C&G Therapy
Cell and gene therapies promise transformative treatments but remain hampered by steep costs across research, manufacturing, and delivery. At the Asembia ASX26 Summit, Aradigm Health CEO Will Shrank highlighted the fragmented U.S. payment landscape as a core barrier to sustainable...
FDA's Oncology Advisors Vote Against 'New Paradigm' In AstraZeneca Trial
The FDA’s oncology advisory committee voted 6‑3 that AstraZeneca’s late‑stage trial of camizestrant, an oral selective estrogen‑receptor degrader (SERD), did not demonstrate a clinically meaningful benefit. AstraZeneca had positioned camizestrant as a potential first‑in‑class oral therapy for hormone‑receptor‑positive metastatic breast...
P‑tau217 Blood Test Predicts Alzheimer’s Risk Early
Good summary of p-tau217, the breakthrough blood test to predict risk of Alzheimer's in people well before onset of symptoms @ScienceMagazine https://t.co/qVJtYR4bnz https://t.co/OhjLExTroG
Siemens Healthineers to Receive $60M in Federal Funding for Key Cancer Therapy
Siemens Healthineers will receive up to $60 million from ARPA‑H over five years, complemented by a $23 million cost‑share, totaling about $83 million. The funding targets development of photon flash therapy, an experimental radiation technique that delivers doses 100 times faster than conventional methods...
Task Switching Raises Risk in Transplant Surgeries, Study Finds
A Virginia Tech analysis of more than 300,000 transplant operations shows that surgeons who switch organ types between consecutive procedures raise one‑year patient mortality by 14.8%. The risk spikes when the switch occurs on the same day, lifting mortality from 4.5%...
Higher Tubular Phosphate Levels Linked to Faster Five-Year Kidney Decline
Researchers at the University of Tsukuba analyzed 308 Japanese participants and found that higher estimated proximal tubular fluid phosphate (ePTFp) levels are linked to a faster decline in kidney function over five years. The ePTFp metric, derived from routine serum...